Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer
Main Authors: | Jie Zhang, Chen Tian, Fang Lv, Jianfei Wang, Wenbo Han, Jun Nie, Ling Dai, Weiheng Hu, Xiaoling Chen, Xiangjuan Ma, Guangming Tian, Di Wu, Sen Han, Yang Wang, Jieran Long, Ziran Zhang, Jian Fang, Henghui Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-04-01
|
Series: | Cancer Communications |
Online Access: | http://link.springer.com/article/10.1186/s40880-019-0363-y |
Similar Items
-
Salvage treatment with anlotinib for advanced non‐small cell lung cancer
by: Di Wu, et al.
Published: (2019-07-01) -
Prognostic factor analysis of patients with small cell lung cancer: Real‐world data from 988 patients
by: Xiangjuan Ma, et al.
Published: (2021-06-01) -
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China
by: Xiaoling Chen, et al.
Published: (2021-03-01) -
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
by: Yang Wang, et al.
Published: (2019-01-01) -
Effects of Local Radiation Combined with Chemotherapy in the treatment of
Patients with Extensive-stage Small Cell Lung Cancer
by: Di WU, et al.
Published: (2015-05-01)